Int J Angiol 2011; 20(2): 095-100
DOI: 10.1055/s-0031-1279683
ORIGINAL ARTICLE

© Thieme Medical Publishers

Predictors of Provisional Stenting in Patients Undergoing Lower Extremity Arterial Interventions

Nicolas W. Shammas1 , Denise Coiner1 , Gail Shammas1 , Michael Jerin1
  • 1Midwest Cardiovascular Research Foundation, Davenport, IA
Further Information

Publication History

Publication Date:
03 June 2011 (online)

ABSTRACT

Predictors of provisional stenting in patients undergoing lower extremity arterial interventions remain unclear. We performed an ad hoc analysis on the predictors of provisional stenting during infrainguinal arterial percutaneous interventions using data from the Percutaneous Lower Extremity Arterial Interventions Using Primary Balloon Angioplasty versus Silverhawk Atherectomy (SA) and Adjunctive Balloon Angioplasty trial. In the above trial, SA of infrainguinal de novo arterial lesions was shown to reduce significantly provisional stenting compared with primary percutaneous transluminal angioplasty (PTA). In this ad hoc analysis, patients were divided into two groups based on whether provisional stenting has occurred. Univariate analysis was conducted between the stent versus the no-stent group. Logistic regression (LR) analysis was performed to model for the predictors of provisional stenting. Variables included were diabetes, presence of moderate calcification (versus none to little), age, gender, hypercholesterolemia, Transatlantic Intersociety Consensus (TASC) D lesion (vs. TASC A to C), and treatment method (primary PTA vs. SA with adjunctive PTA). By LR analysis, predictors of stenting were as follows: moderate calcification (odds ratio [OR] 6.56, 95% confidence interval [CI] 1.21 to 35.56, p = 0.029), primary PTA (vs. SA) (OR 0.19, 95% CI 0.04 to 0.93, p = 0.04), and TASC D lesions (vs. A to C) (OR 0.10, 95% CI 0.01 to 0.87, p = 0.037). Provisional stenting in infrainguinal interventions is predicted by the use of primary PTA, presence of moderate calcification, and TASC D lesions after controlling for gender, age, hypercholesterolemia, and diabetes.

REFERENCES

  • 1 Kasapis C, Henke P K, Chetcuti S J et al.. Routine stent implantation vs. percutaneous transluminal angioplasty in femoropopliteal artery disease: a meta-analysis of randomized controlled trials.  Eur Heart J. 2009;  30 44-55
  • 2 Krankenberg H, Schlüter M, Steinkamp H J et al.. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST).  Circulation. 2007;  116 285-292
  • 3 Schillinger M, Sabeti S, Loewe C et al.. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery.  N Engl J Med. 2006;  354 1879-1888
  • 4 Zorger N, Manke C, Lenhart M et al.. Peripheral arterial balloon angioplasty: effect of short versus long balloon inflation times on the morphologic results.  J Vasc Interv Radiol. 2002;  13 355-359
  • 5 Ramaiah V, Gammon R, Kiesz S TALON Registry et al. Midterm outcomes from the TALON Registry: treating peripherals with SilverHawk: outcomes collection.  J Endovasc Ther. 2006;  13 592-602
  • 6 Zeller T, Rastan A, Sixt S et al.. Long-term results after directional atherectomy of femoro-popliteal lesions.  J Am Coll Cardiol. 2006;  48 1573-1578
  • 7 Biskup N I, Ihnat D M, Leon L R, Gruessner A C, Mills J L. Infrainguinal atherectomy: a retrospective review of a single-center experience.  Ann Vasc Surg. 2008;  22 776-782
  • 8 Adlakha S, Sheikh M, Wu J et al.. Stent fracture in the coronary and peripheral arteries.  J Interv Cardiol. 2010;  23 411-419
  • 9 Scheinert D, Scheinert S, Sax J et al.. Prevalence and clinical impact of stent fractures after femoropopliteal stenting.  J Am Coll Cardiol. 2005;  45 312-315
  • 10 Laird J R. Limitations of percutaneous transluminal angioplasty and stenting for the treatment of disease of the superficial femoral and popliteal arteries.  J Endovasc Ther. 2006;  13 (Suppl 2) II30-II40
  • 11 Shammas N W, Coiner D, Shammas G, Dippel E, Christensen L, Jerin M. Percutaneous Lower Extremity Arterial Interventions Using Balloon Angioplasty Versus Silverhawk Atherectomy: Results of the SMARTHAWK Randomized Trial. Presented at the Society for Cardiovascular Angiography & Interventions (SCAI) 32nd Annual Scientific Sessions in Las Vegas from May 6–9, 2009.  Catheter Cardiovasc Interv. 2009;  73 S42
  • 12 Schlager O, Dick P, Sabeti S et al.. Long-segment SFA stenting—the dark sides: in-stent restenosis, clinical deterioration, and stent fractures.  J Endovasc Ther. 2005;  12 676-684

Nicolas W. ShammasM.D. M.S. F.I.C.A. 

Director, Midwest Cardiovascular Research Foundation, Cardiovascular Medicine, PC

1236 E. Rusholme, Suite 300, Davenport, IA 52803

Email: shammas@mchsi.com

    >